Our Perspective
Combining considered, thought provoking ideas with expertise to showcase our point of view on what matters most
2026 and Beyond: Boosting UK Life Sciences Investment
The ‘2026 and Beyond: Boosting UK Life Sciences’ Investment Breakfast was hosted on the 4th of December 2025 by 5654 & Company, in collaboration with Bird & Bird, Citi, Negotient, and Peel Hunt.
AI Heats Up: From Promise to Patient Impact
Associate Director Charlotte Dawson attended this year’s TechBio UK Conference, where the conversation wasn’t about “what if”, it was about results.
Transforming the NHS: A Triple Dividend
Transforming the NHS: A Triple Dividend - 5654 & Company publishes a paper on how innovation, partnership and investment can deliver better patient outcomes, improved NHS productivity and stronger economic growth
